Evvy, a company focused on women's health research, has secured $40 million in Series B funding. The investment was led by Catalio Capital Management and will support Evvy's efforts to advance research using vaginal microbiome data. This funding aims to further understand and improve women's health. AI
IMPACT This funding could accelerate the application of AI and machine learning in analyzing complex biological data for women's health.
RANK_REASON Significant funding round for a company in the health tech sector. [lever_c_demoted from significant: ic=1 ai=0.4]
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →